Morrison Foerster is no stranger to complex, high-stakes and bet-the-company disputes. Our clients, whether they are Fortune 100 multinationals or early-stage tech companies, turn to us for help with their most difficult legal issues. We work closely with them to understand their businesses, identify potential areas of legal exposure, devise strategies to manage risk, and, where appropriate, resolve disputes short of trial.
If it comes to trial, Morrison Foerster litigators win. Our clients have prevailed in hundreds of cases before judges and juries. Our more than 350 litigators include some of the top trial and appellate lawyers in the U.S., Japan, China, and the UK, with leading practitioners in intellectual property, securities, commercial litigation, antitrust, white-collar criminal defense, product liability, class actions, unfair competition, financial services, trade secrets, privacy, and employment litigation. Our team includes more than 130 lawyers and patent agents with technical degrees and experience as engineers and other technical professionals. This experience provides our clients with a competitive edge in analyzing claims and defenses with respect to technology, life sciences, financial services, and consumer products.
Morrison Foerster is consistently ranked for its litigation capabilities throughout the United States, Asia and Europe by leading directories such as Chambers and Partners and Legal 500. In the 2020 edition of BTI Consulting’s Litigation Outlook report, MoFo was named to its list of “Awesome Opponents,” one of 10 firms that in-house counsel most feared seeing across the table in litigation. Additionally, Financial Times recognized MoFo as one of the Most Innovative Law Firms in North America and Asia-Pacific in each region’s most recent Innovative Lawyers report, which assess lawyers on their innovation for clients and the broader legal industry. Our litigators are frequently recognized in their respective fields by Law360, Daily Journal, National Law Journal and The American Lawyer.